SUSQUEHANNA INTERNATIONAL GROUP, LLP - NRX PHARMACEUTICALS INC ownership

NRX PHARMACEUTICALS INC's ticker is NRXP and the CUSIP is 629444100. A total of 38 filers reported holding NRX PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.30 and the average weighting 0.0%.

Quarter-by-quarter ownership
SUSQUEHANNA INTERNATIONAL GROUP, LLP ownership history of NRX PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$8,320
-4.2%
31,999
+76.8%
0.00%
Q2 2023$8,688
-86.7%
18,100
-81.7%
0.00%
Q1 2023$65,151
-32.3%
98,823
+13.9%
0.00%
Q4 2022$96,268
-12.5%
86,728
-41.4%
0.00%
Q3 2022$110,000
-11.3%
147,885
-28.0%
0.00%
Q2 2022$124,000
-80.0%
205,374
-18.8%
0.00%
Q1 2022$620,000
-81.0%
253,009
-62.9%
0.00%
Q4 2021$3,256,000
+6.1%
681,712
+106.0%
0.00%
Q3 2021$3,068,000330,9280.00%
Other shareholders
NRX PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Texas Capital Bank Wealth Management Services Inc 63,290$41,7140.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 230,700$152,0540.00%
Virtu Financial LLC 46,210$300.00%
United Asset Strategies, Inc. 18,300$12,0620.00%
HBK Sorce Advisory LLC 29,230$19,2660.00%
UBS Group AG 18,611$12,2650.00%
NewEdge Advisors, LLC 2,125$1,4010.00%
OSAIC HOLDINGS, INC. 27,225$17,9330.00%
BANK OF AMERICA CORP /DE/ 30,000$19,7700.00%
WELLS FARGO & COMPANY/MN 5,309$3,5000.00%
View complete list of NRX PHARMACEUTICALS INC shareholders